Skip to content
10-Q

Quarterly Report

Miromatrix Medical Inc.

0001558370-22-013620

← back to feed
Filed
Aug 15, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 10, 2022 20.9M sh
Long Term Debt Q2 2022 · Jun 30, 2022 $386K
Long Term Debt Q2 2022 · Dec 31, 2021 $386K
Short Term Debt Q2 2022 · Jun 30, 2022 $38.4K
Short Term Debt Q2 2022 · Dec 31, 2021 $333.85K
Current Liabilities Q2 2022 · Jun 30, 2022 $3.74M
Current Liabilities Q2 2022 · Dec 31, 2021 $4.56M
Total Liabilities Q2 2022 · Jun 30, 2022 $7.64M
Total Liabilities Q2 2022 · Dec 31, 2021 $6.8M
Current Assets Q2 2022 · Jun 30, 2022 $33.96M
Current Assets Q2 2022 · Dec 31, 2021 $55.34M
Total Assets Q2 2022 · Jun 30, 2022 $47.65M
Total Assets Q2 2022 · Dec 31, 2021 $60.93M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $52.81M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $66.53M
Shares Diluted Q2 2022 · Jun 30, 2021 2.91M sh
Shares Diluted Q2 2022 · Jun 30, 2021 2.59M sh
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$5.39M
Stockholders Equity Q2 2022 · Jun 30, 2021 $63.41M
Stockholders Equity Q2 2022 · Mar 31, 2021 −$51.31M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$51.03M
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.27
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.60
Eps Basic Q2 2022 · Jun 30, 2021 −$1.27
Eps Basic Q2 2022 · Jun 30, 2021 −$1.60
Sga Expense Q2 2022 · Jun 30, 2021 $786.32K
Sga Expense Q2 2022 · Jun 30, 2021 $1.35M
Rd Expense Q2 2022 · Jun 30, 2021 $2.48M
Rd Expense Q2 2022 · Jun 30, 2021 $4.35M
Net Income Q2 2022 · Jun 30, 2021 −$3.7M
Net Income Q2 2022 · Jun 30, 2021 −$4.14M
Operating Income Q2 2022 · Jun 30, 2021 −$3.57M
Operating Income Q2 2022 · Jun 30, 2021 −$6.29M
Gross Profit Q2 2022 · Jun 30, 2021 −$115.86K
Gross Profit Q2 2022 · Jun 30, 2021 −$234.75K
Cost Of Revenue Q2 2022 · Jun 30, 2021 $125K
Cost Of Revenue Q2 2022 · Jun 30, 2021 $250K
Revenue Q2 2022 · Jun 30, 2021 $9.14K
Revenue Q2 2022 · Jun 30, 2021 $15.25K